Evaluation of non-invasive hemoglobin measurement in blood donors at a tertiary care hospital, Bangkok, Thailand

dc.contributor.authorDangwilailert R.
dc.contributor.authorLekmak S.
dc.contributor.authorPromlee D.
dc.contributor.authorPongkunakorn T.
dc.contributor.authorPermpikul P.
dc.contributor.correspondenceDangwilailert R.
dc.contributor.otherMahidol University
dc.date.accessioned2026-05-16T18:40:20Z
dc.date.available2026-05-16T18:40:20Z
dc.date.issued2026-05-01
dc.description.abstractBackground Hemoglobin (Hb) assessment is crucial to prevent blood donation from anemic donors. Most measurements are invasive and painful; however, an alternative, non-invasive hemoglobin measurement is available. This study aimed to compare non-invasive and point-of-care invasive hemoglobin test results with those from an automated blood analyzer in blood donors. Methods Qualified blood donors were enrolled at a tertiary care hospital in Bangkok, Thailand. Hemoglobin was initially measured by the non-invasive device (Rad-67 Pulse CO-Oximeter) and a point-of-care invasive hemoglobin screening device (Mission HemoPro). Participants with point-of-care invasive hemoglobin ≥ 12.5 g/dL were eligible to donate, and during donation, standard hemoglobin measurements were obtained using an automated analyzer, XN-550. Those who were ineligible with point-of-care invasive hemoglobin < 12.5 g/dL underwent additional blood sampling for hemoglobin measurement by an automated analyzer. Correlation and agreement between non-invasive, point-of-care, and automated hemoglobin measurements were assessed with Intraclass Correlation Coefficient (ICC) and Bland-Altman plots, while satisfaction was evaluated using a Likert scale. Results Of 300 participants, 295 had complete data. Of these, 169 were male (57.28%). Average non-invasive, point-of-care, and automated hemoglobin levels were 14.38 ± 1.12 g/dL, 13.65 ± 0.70 g/dL, and 13.90 ± 1.16 g/dL, respectively. The ICC between noninvasive, point-of-care, and automated hemoglobin measurement was 0.600 (95% CI: 0.522–0.668) and 0.897 (95% CI: 0.872–0.957). The sensitivity of the noninvasive Hb measurement was poor for detecting anemic donors when the Hb cut-off was set at 12.5 g/dL. This method received significantly higher satisfaction than the routinely used invasive device. Conclusion The non-invasive Hb measurement in blood donors showed moderate agreement with the standard test, but the sensitivity was poor when the cut-off hemoglobin was set at 12.5 g/dl. Since donor satisfaction was higher, this method may be used as an alternative screening tool, provided a higher Hb cut-off value is used.
dc.identifier.citationPlos One Vol.21 No.5 May (2026)
dc.identifier.doi10.1371/journal.pone.0348447
dc.identifier.eissn19326203
dc.identifier.scopus2-s2.0-105038216561
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/116781
dc.rights.holderSCOPUS
dc.subjectMultidisciplinary
dc.titleEvaluation of non-invasive hemoglobin measurement in blood donors at a tertiary care hospital, Bangkok, Thailand
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105038216561&origin=inward
oaire.citation.issue5 May
oaire.citation.titlePlos One
oaire.citation.volume21
oairecerif.author.affiliationSiriraj Hospital

Files

Collections